Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s11060-008-9720-4.

Title:
Nuclear survivin expression predicts poorer prognosis in glioblastoma | Journal of Neuro-Oncology
Description:
Survivin is a member of the inhibitor of apoptosis family, and is expressed in various malignant tumors. Survivin overexpression has been reported to be a poorer prognostic factor in various malignancies. However, the prognostic value of survivin expression in patients with glioblastoma is still controversial. Therefore, in this study the role of survivin as a predictor for survival was investigated in patients with glioblastoma. Tissue specimens were obtained from 66 patients with glioblastoma treated with radiotherapy. Survivin expression was detected by an immunohistochemical method. Nuclear and cytoplasm survivin scores were defined by using the cell positivity and staining intensity. The scores were defined as follows, 0 (no staining), 1 (less than 50% of cell positivity and any staining), 2 (more than 50% of cell positivity and weak to moderate intensity) and 3 (more than 50% of cell positivity and strong intensity). The correlation between survivin scores and the overall survival rate was evaluated. Nuclear and cytoplasm survivin staining were noted in 47 and 58 patients, respectively. The number of patients with nuclear survivin score of 0, 1, 2 and 3, were 19 (28.8%), 26 (39.4%), 9 (13.6%) and 12 (18.2%), respectively. The 3-year overall survival rate of the nuclear survivin score 3 was 0%, significantly lower than the 11.6% of the nuclear survivin score ≀2 (P = 0.0003). Cytoplasm survivin score did not correlate with the prognosis. Nuclear survivin expression may be a useful biomarker for predicting prognosis in patients with glioblastoma.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {πŸ“š}

  • Education
  • Science
  • Health & Fitness

Content Management System {πŸ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {πŸ’Έ}

We can't see how the site brings in money.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {πŸ”}

survivin, article, google, scholar, pubmed, cas, cancer, expression, cell, nuclear, prognostic, glioblastoma, patients, prognosis, human, carcinoma, apoptosis, survival, res, suzuki, japan, access, cells, doisjbjc, dois, department, gunma, maebashi, privacy, cookies, content, journal, predicts, cytoplasm, localization, glioma, protein, marker, oncol, publish, search, study, oka, itoh, inhibitor, tumors, positivity, staining, correlation, score,

Topics {βœ’οΈ}

month download article/chapter small-cell lung cancer neuro-oncology aims full article pdf iap protein survivin poorer prognostic factor privacy choices/manage cookies caspase-independent mechanisms centrosome amplification induced human glioma cells human tumor cells transitional cell carcinoma differential subcellular localization survivin subcellular localization nuclear survivin score apoptotic markers brain tumors tumor cell nuclei human hepatocellular carcinoma cytoplasm survivin score article shirai nuclear survivin expression recurrent colorectal carcinoma european economic area shin-ei noda elevating cellular senescence related subjects mitotic spindle checkpoint dominant-negative isoform secondary human glioblastoma takasaki national hospital conditions privacy policy article journal human survivin promoter elevated expression level soft-tissue sarcomas transcriptional targeting strategy cytoplasm survivin scores gene knockout phenotype negative prognostic marker independent prognostic marker survivin-beta/2b survivin expression suppresses survivin suppression enhances check access instant access cancer specific therapy p34cdc2 survival checkpoint article log accepting optional cookies

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:Nuclear survivin expression predicts poorer prognosis in glioblastoma
         description:Survivin is a member of the inhibitor of apoptosis family, and is expressed in various malignant tumors. Survivin overexpression has been reported to be a poorer prognostic factor in various malignancies. However, the prognostic value of survivin expression in patients with glioblastoma is still controversial. Therefore, in this study the role of survivin as a predictor for survival was investigated in patients with glioblastoma. Tissue specimens were obtained from 66 patients with glioblastoma treated with radiotherapy. Survivin expression was detected by an immunohistochemical method. Nuclear and cytoplasm survivin scores were defined by using the cell positivity and staining intensity. The scores were defined as follows, 0 (no staining), 1 (less than 50% of cell positivity and any staining), 2 (more than 50% of cell positivity and weak to moderate intensity) and 3 (more than 50% of cell positivity and strong intensity). The correlation between survivin scores and the overall survival rate was evaluated. Nuclear and cytoplasm survivin staining were noted in 47 and 58 patients, respectively. The number of patients with nuclear survivin score of 0, 1, 2 and 3, were 19 (28.8%), 26 (39.4%), 9 (13.6%) and 12 (18.2%), respectively. The 3-year overall survival rate of the nuclear survivin score 3 was 0%, significantly lower than the 11.6% of the nuclear survivin score ≀2 (PΒ =Β 0.0003). Cytoplasm survivin score did not correlate with the prognosis. Nuclear survivin expression may be a useful biomarker for predicting prognosis in patients with glioblastoma.
         datePublished:2008-10-25T00:00:00Z
         dateModified:2008-10-25T00:00:00Z
         pageStart:353
         pageEnd:358
         sameAs:https://doi.org/10.1007/s11060-008-9720-4
         keywords:
            Survivin
            Glioblastoma
            Radiotherapy
            Nuclear
            Cytoplasm
            Oncology
            Neurology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-008-9720-4/MediaObjects/11060_2008_9720_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-008-9720-4/MediaObjects/11060_2008_9720_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-008-9720-4/MediaObjects/11060_2008_9720_Fig3_HTML.gif
         isPartOf:
            name:Journal of Neuro-Oncology
            issn:
               1573-7373
               0167-594X
            volumeNumber:91
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Katsuyuki Shirai
               affiliation:
                     name:Gunma University Graduate School of Medicine
                     address:
                        name:Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yoshiyuki Suzuki
               affiliation:
                     name:Gunma University Graduate School of Medicine
                     address:
                        name:Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Kuniyuki Oka
               affiliation:
                     name:Mito Saiseikai General Hospital
                     address:
                        name:Department of Pathology, Mito Saiseikai General Hospital, Mito, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shin-ei Noda
               affiliation:
                     name:Gunma University Graduate School of Medicine
                     address:
                        name:Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hiroyuki Katoh
               affiliation:
                     name:Gunma University Graduate School of Medicine
                     address:
                        name:Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yoshihiko Suzuki
               affiliation:
                     name:Takasaki National Hospital
                     address:
                        name:Department of Radiology, Takasaki National Hospital, Takasaki, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jun Itoh
               affiliation:
                     name:Maebashi Red Cross Hospital
                     address:
                        name:Department of Radiology, Maebashi Red Cross Hospital, Maebashi, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hideaki Itoh
               affiliation:
                     name:Maebashi Red Cross Hospital
                     address:
                        name:Department of Pathology, Maebashi Red Cross Hospital, Maebashi, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shogo Ishiuchi
               affiliation:
                     name:Gunma University Graduate School of Medicine
                     address:
                        name:Department of Neurosurgery, Gunma University Graduate School of Medicine, Maebashi, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hideyuki Sakurai
               affiliation:
                     name:Gunma University Graduate School of Medicine
                     address:
                        name:Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Masatoshi Hasegawa
               affiliation:
                     name:Gunma University Graduate School of Medicine
                     address:
                        name:Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Takashi Nakano
               affiliation:
                     name:Gunma University Graduate School of Medicine
                     address:
                        name:Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Nuclear survivin expression predicts poorer prognosis in glioblastoma
      description:Survivin is a member of the inhibitor of apoptosis family, and is expressed in various malignant tumors. Survivin overexpression has been reported to be a poorer prognostic factor in various malignancies. However, the prognostic value of survivin expression in patients with glioblastoma is still controversial. Therefore, in this study the role of survivin as a predictor for survival was investigated in patients with glioblastoma. Tissue specimens were obtained from 66 patients with glioblastoma treated with radiotherapy. Survivin expression was detected by an immunohistochemical method. Nuclear and cytoplasm survivin scores were defined by using the cell positivity and staining intensity. The scores were defined as follows, 0 (no staining), 1 (less than 50% of cell positivity and any staining), 2 (more than 50% of cell positivity and weak to moderate intensity) and 3 (more than 50% of cell positivity and strong intensity). The correlation between survivin scores and the overall survival rate was evaluated. Nuclear and cytoplasm survivin staining were noted in 47 and 58 patients, respectively. The number of patients with nuclear survivin score of 0, 1, 2 and 3, were 19 (28.8%), 26 (39.4%), 9 (13.6%) and 12 (18.2%), respectively. The 3-year overall survival rate of the nuclear survivin score 3 was 0%, significantly lower than the 11.6% of the nuclear survivin score ≀2 (PΒ =Β 0.0003). Cytoplasm survivin score did not correlate with the prognosis. Nuclear survivin expression may be a useful biomarker for predicting prognosis in patients with glioblastoma.
      datePublished:2008-10-25T00:00:00Z
      dateModified:2008-10-25T00:00:00Z
      pageStart:353
      pageEnd:358
      sameAs:https://doi.org/10.1007/s11060-008-9720-4
      keywords:
         Survivin
         Glioblastoma
         Radiotherapy
         Nuclear
         Cytoplasm
         Oncology
         Neurology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-008-9720-4/MediaObjects/11060_2008_9720_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-008-9720-4/MediaObjects/11060_2008_9720_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-008-9720-4/MediaObjects/11060_2008_9720_Fig3_HTML.gif
      isPartOf:
         name:Journal of Neuro-Oncology
         issn:
            1573-7373
            0167-594X
         volumeNumber:91
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Katsuyuki Shirai
            affiliation:
                  name:Gunma University Graduate School of Medicine
                  address:
                     name:Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yoshiyuki Suzuki
            affiliation:
                  name:Gunma University Graduate School of Medicine
                  address:
                     name:Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Kuniyuki Oka
            affiliation:
                  name:Mito Saiseikai General Hospital
                  address:
                     name:Department of Pathology, Mito Saiseikai General Hospital, Mito, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shin-ei Noda
            affiliation:
                  name:Gunma University Graduate School of Medicine
                  address:
                     name:Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hiroyuki Katoh
            affiliation:
                  name:Gunma University Graduate School of Medicine
                  address:
                     name:Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yoshihiko Suzuki
            affiliation:
                  name:Takasaki National Hospital
                  address:
                     name:Department of Radiology, Takasaki National Hospital, Takasaki, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jun Itoh
            affiliation:
                  name:Maebashi Red Cross Hospital
                  address:
                     name:Department of Radiology, Maebashi Red Cross Hospital, Maebashi, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hideaki Itoh
            affiliation:
                  name:Maebashi Red Cross Hospital
                  address:
                     name:Department of Pathology, Maebashi Red Cross Hospital, Maebashi, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shogo Ishiuchi
            affiliation:
                  name:Gunma University Graduate School of Medicine
                  address:
                     name:Department of Neurosurgery, Gunma University Graduate School of Medicine, Maebashi, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hideyuki Sakurai
            affiliation:
                  name:Gunma University Graduate School of Medicine
                  address:
                     name:Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Masatoshi Hasegawa
            affiliation:
                  name:Gunma University Graduate School of Medicine
                  address:
                     name:Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Takashi Nakano
            affiliation:
                  name:Gunma University Graduate School of Medicine
                  address:
                     name:Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Journal of Neuro-Oncology
      issn:
         1573-7373
         0167-594X
      volumeNumber:91
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Gunma University Graduate School of Medicine
      address:
         name:Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
         type:PostalAddress
      name:Gunma University Graduate School of Medicine
      address:
         name:Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
         type:PostalAddress
      name:Mito Saiseikai General Hospital
      address:
         name:Department of Pathology, Mito Saiseikai General Hospital, Mito, Japan
         type:PostalAddress
      name:Gunma University Graduate School of Medicine
      address:
         name:Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
         type:PostalAddress
      name:Gunma University Graduate School of Medicine
      address:
         name:Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
         type:PostalAddress
      name:Takasaki National Hospital
      address:
         name:Department of Radiology, Takasaki National Hospital, Takasaki, Japan
         type:PostalAddress
      name:Maebashi Red Cross Hospital
      address:
         name:Department of Radiology, Maebashi Red Cross Hospital, Maebashi, Japan
         type:PostalAddress
      name:Maebashi Red Cross Hospital
      address:
         name:Department of Pathology, Maebashi Red Cross Hospital, Maebashi, Japan
         type:PostalAddress
      name:Gunma University Graduate School of Medicine
      address:
         name:Department of Neurosurgery, Gunma University Graduate School of Medicine, Maebashi, Japan
         type:PostalAddress
      name:Gunma University Graduate School of Medicine
      address:
         name:Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
         type:PostalAddress
      name:Gunma University Graduate School of Medicine
      address:
         name:Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
         type:PostalAddress
      name:Gunma University Graduate School of Medicine
      address:
         name:Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Katsuyuki Shirai
      affiliation:
            name:Gunma University Graduate School of Medicine
            address:
               name:Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
               type:PostalAddress
            type:Organization
      name:Yoshiyuki Suzuki
      affiliation:
            name:Gunma University Graduate School of Medicine
            address:
               name:Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Kuniyuki Oka
      affiliation:
            name:Mito Saiseikai General Hospital
            address:
               name:Department of Pathology, Mito Saiseikai General Hospital, Mito, Japan
               type:PostalAddress
            type:Organization
      name:Shin-ei Noda
      affiliation:
            name:Gunma University Graduate School of Medicine
            address:
               name:Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
               type:PostalAddress
            type:Organization
      name:Hiroyuki Katoh
      affiliation:
            name:Gunma University Graduate School of Medicine
            address:
               name:Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
               type:PostalAddress
            type:Organization
      name:Yoshihiko Suzuki
      affiliation:
            name:Takasaki National Hospital
            address:
               name:Department of Radiology, Takasaki National Hospital, Takasaki, Japan
               type:PostalAddress
            type:Organization
      name:Jun Itoh
      affiliation:
            name:Maebashi Red Cross Hospital
            address:
               name:Department of Radiology, Maebashi Red Cross Hospital, Maebashi, Japan
               type:PostalAddress
            type:Organization
      name:Hideaki Itoh
      affiliation:
            name:Maebashi Red Cross Hospital
            address:
               name:Department of Pathology, Maebashi Red Cross Hospital, Maebashi, Japan
               type:PostalAddress
            type:Organization
      name:Shogo Ishiuchi
      affiliation:
            name:Gunma University Graduate School of Medicine
            address:
               name:Department of Neurosurgery, Gunma University Graduate School of Medicine, Maebashi, Japan
               type:PostalAddress
            type:Organization
      name:Hideyuki Sakurai
      affiliation:
            name:Gunma University Graduate School of Medicine
            address:
               name:Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
               type:PostalAddress
            type:Organization
      name:Masatoshi Hasegawa
      affiliation:
            name:Gunma University Graduate School of Medicine
            address:
               name:Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
               type:PostalAddress
            type:Organization
      name:Takashi Nakano
      affiliation:
            name:Gunma University Graduate School of Medicine
            address:
               name:Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
      name:Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
      name:Department of Pathology, Mito Saiseikai General Hospital, Mito, Japan
      name:Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
      name:Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
      name:Department of Radiology, Takasaki National Hospital, Takasaki, Japan
      name:Department of Radiology, Maebashi Red Cross Hospital, Maebashi, Japan
      name:Department of Pathology, Maebashi Red Cross Hospital, Maebashi, Japan
      name:Department of Neurosurgery, Gunma University Graduate School of Medicine, Maebashi, Japan
      name:Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
      name:Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
      name:Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {πŸ”—}(199)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Clipboard.js
  • Prism.js

CDN Services {πŸ“¦}

  • Crossref

5.18s.